Logo


'Most Hepatitis C affected untreated in India'

With 15 million Indians affected by chronic Hepatitis C infection, a majority of them are not getting treated due to lack of public awareness on the spread of virus and also the preventive steps. Though the cost of treating Hepatitis C virus (HCV) patients had come down drastically from $1,000 a pill few years ago to $100 now, very few are aware of having the virus in their body and most of them are ending up with liver cancer. Domestic drug manufacturers, in arrangement with Gilead, are now producing the affordable generic version of Sofosbuvir for HCV treatment. A World Health ...